Serve Robotics Q2 Miss Confirms Utilization Concerns, But No Change to Wait Thesis

What happened

Serve Robotics reported Q2 2026 revenue of $3.2 million, missing the Zacks Consensus Estimate by 8.5%, while EPS missed by 15.9%, and the net loss widened year over year despite revenue rising sharply from $0.6 million in Q2 2025. This was already reflected in the company's July guidance cut to $9-10 million for full-year 2026, driven by lower-than-expected Uber Eats delivery volume, including a Q2 decline and removal of projected second-half demand. Meanwhile, active robots rose to 792 daily from 160 a year earlier, but this remains far below the over 2,000 deployed fleet, underscoring the monetization gap. Healthcare via Diligent added seven hospital extensions and two new hospitals, but it is still too small to offset outdoor volatility. The market has reacted by sending the stock down over 50% in the past year, and the balance-sheet cash of $240 million provides some support but does not negate the fundamental dependency on platform order allocation.

Implication

The Q2 report confirms the key risk identified in our DeepValue report: revenue growth is not yet translating into sufficient order density from partner platforms, with Uber Eats volume declining and DoorDash growth not fully offsetting. The stock's 51% decline over the past year reflects a repricing from a growth story to a show-me story, and the current price near $5 is close to our attractive entry of $4.25 but lacks a catalyst until we see active robots above 811 and supply hours above 10,051 in the next filing. Investors should monitor the next quarterly filing for signs that the guidance cut was a one-time reset rather than the start of repeated downgrades; any further cut or continued Uber weakness would likely push the stock toward the bear case of $3.50. Conversely, if active robots exceed 900, healthcare expands, and no new financing is needed, the stock could re-rate toward our base case of $5.50 or bull case of $7.50. In the meantime, the $240 million cash position funds at least 12 months, reducing immediate liquidity risk, but dilution remains a real threat if cash burn continues at $42 million per quarter without revenue acceleration.

Thesis delta

The Zacks article adds no new information beyond confirming the Q2 miss, which was already reflected in our report's analysis of the July guidance cut and weak utilization metrics. The core thesis remains that Serve is a monetization test, and the miss reinforces the view that the company does not control its primary revenue driver. No change to rating or price targets; we await the next filing for evidence of inflection.